LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 107 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -17.9% | 19,565 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | -99.9% | 19,565 | +29.0% | 0.00% | – |
| Q1 2022 | $23,000 | -71.2% | 15,165 | -53.5% | 0.00% | – |
| Q4 2021 | $80,000 | +90.5% | 32,612 | +97.1% | 0.00% | – |
| Q3 2021 | $42,000 | -14.3% | 16,543 | -3.1% | 0.00% | – |
| Q2 2021 | $49,000 | +276.9% | 17,067 | +11.9% | 0.00% | – |
| Q1 2020 | $13,000 | -13.3% | 15,254 | -7.3% | 0.00% | – |
| Q4 2019 | $15,000 | +7.1% | 16,451 | +13.1% | 0.00% | – |
| Q3 2019 | $14,000 | – | 14,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $28,160,000 | 3.29% |
| Defender Capital, LLC. | 4,416,590 | $3,657,000 | 2.67% |
| Prescott General Partners LLC | 1,851,851 | $1,534,000 | 0.13% |
| Laidlaw Wealth Management LLC | 107,379 | $89,000 | 0.06% |
| Northeast Financial Consultants Inc | 523,756 | $434,000 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $37,000 | 0.04% |
| DAFNA Capital Management LLC | 95,000 | $79,000 | 0.03% |
| Summit X, LLC | 30,700 | $25,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 529,039 | $438,000 | 0.01% |
| Keudell/Morrison Wealth Management | 10,105 | $8,000 | 0.01% |